The Chinese have been integrating cancer treatment for the past 60 years. Using conventional and Chinese traditional medicine, this integration has evolved into a sophisticated hybrid of medicine that has generated a great deal of well-designed research demonstrating that the use of combined care can improve outcomes for patients with cancer. This article seeks to explain the integration in terms of treatment of colorectal cancer and a colorectal cancer case with Duke's stage C adenocarcinoma.
No takes yet. Share an insight, caveat, or question.
Tai Lahans (2007) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: